Characterization of Thermoregulatory Efferents to the Paraventricular Nucleus of the Rat Hypothalamus by McLane, Virginia D.
W&M ScholarWorks 
Undergraduate Honors Theses Theses, Dissertations, & Master Projects 
5-2011 
Characterization of Thermoregulatory Efferents to the 
Paraventricular Nucleus of the Rat Hypothalamus 
Virginia D. McLane 
College of William and Mary 
Follow this and additional works at: https://scholarworks.wm.edu/honorstheses 
Recommended Citation 
McLane, Virginia D., "Characterization of Thermoregulatory Efferents to the Paraventricular Nucleus of the 
Rat Hypothalamus" (2011). Undergraduate Honors Theses. Paper 394. 
https://scholarworks.wm.edu/honorstheses/394 
This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at 
W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 
1 
 
 
 
 
 
 
 
 
 
 
 
Characterization of thermoregulatory efferents to the  
paraventricular nucleus of the rat hypothalamus 
 
 
 
 
A thesis submitted in partial fulfillment of the requirement  
for the degree of Bachelor of Science in Neuroscience from 
The College of William and Mary 
 
By 
 
Virginia D. McLane 
 
 
Accepted for ___________________________________ 
                                                                               (Honors, High Honors, Highest Honors) 
 
________________________________________  
                                          Dr. John D. Griffin, Director 
 
________________________________________  
                     Dr. Joshua Burk 
 
________________________________________  
                                 Dr. Matthew Wawersik 
 
 
 
 
Williamsburg, VA  
May 2, 2011 
 
 
2 
 
Table of Contents 
 
I. Abstract 3
II. Introduction 4
III. Methods 20
IV. Results 27
V. Discussion 35
VI. References 41
VII. Acknowledgements 45
 
 
3 
 
Abstract 
The paraventricular nucleus of the hypothalamus (PVN) is the gatekeeper to temperature-
modulating hormones such as vasopressin. Indeed, it is in theory a key target region for 
thermoregulatory efferents of the preoptic area of the anterior hypothalamus (POAH). Although 
several retrograde labeling studies have identified a connection between the POAH and PVN, 
none have directly characterized the thermoregulatory nature of this interaction. We will identify 
the phenotype of these connections by injecting retrograde-labeling nanoprobes into the PVN of 
live tissue slices and quantified labeled POAH somas. These probes are designed for selective 
uptake by glutamate-releasing axon terminals, after which they diffuse rapidly to the neuron 
soma. Our results indicate that glutamatergic neurons do project from the POAH to the PVN. 
This technique will allow for further electrophysiologic studies to identify the thermosensitivity 
of neurons with a known connectivity and phenotype. 
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Introduction 
 Does the POAH interact directly with the PVN? If so, how? To address these questions, 
we must first lay out the theoretical foundations for central thermoregulation, the PVN’s major 
roles in normal biological function, and what evidence exists of a functional relationship between 
the thermoregulatory POAH and the PVN. 
 
 
1. Central Thermoregulation and the Hypothalamus 
As endotherms, mammals maintain a carefully regulated core temperature of ~37°C. 
Although this temperature can vary slightly across individuals, time of day, and body states, the 
mammalian body works continuously to maintain a set-point temperature via metabolic, 
physiological, and behavioral mechanisms (Hammel, 1968). This set-point is both determined 
and maintained by the neurons in the POAH, which serves as the central nucleus in the 
hypothalamus for maintaining thermoregulatory homeostasis. Despite being a subject of research 
for the better part of a century, the mechanisms by which the POAH maintains thermal 
homeostasis continue to be elucidated. 
The POAH was originally identified by researchers of the mid-20th century, who 
implanted thermodes directly into live animal brain tissue and observed the heat loss and heat 
retention responses that could be evoked with direct cooling or warming of various regions of 
interest. These studies discovered several regions of the brain stem and spinal cord that generate 
thermoregulatory responses in the periphery. Of particular interest was the POAH, which 
exhibited both exceptional sensitivity to subtle changes in temperature and a clear influence on 
lower thermoregulatory effector areas (Boulant, 2006).  
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Located in the rostral hypothalamus, the POAH receives information on peripheral 
temperature from cutaneous temperature-sensitive sensory neurons, which convey temperature 
information to the brain through the lateral spinothalamic tract. As shown by the thermode-
implant studies, the POAH can also respond to changes in central temperature. If cooled below 
37°C, the POAH induces mechanisms that both conserve heat and create it, ranging from 
cutaneous vasoconstriction to shivering (Griffin, 2004). Warming of the POAH above 37°C can 
lead to cutaneous vasodilation, sweating, and other heat loss mechanisms (Boulant, 2006). This 
is a result of the properties of the POAH neurons themselves, some of which display an inherent 
thermosensitivity (Boulant, 2000). Overall, the POAH acts as the thermostat of the brain, 
collecting temperature data and inducing the required physiological and behavioral changes to 
maintain homeostasis. 
 
 
2. The POAH Synaptic Network 
An organism’s temperature set-point is both created and maintained by POAH neurons, 
their inherent properties, and the synaptic network they form. These neurons can be classified 
most broadly into silent and tonically active neurons, with the former showing no activity in vitro 
and the latter continuing to fire spontaneous action potentials ex vivo. Amongst the 
spontaneously active neurons, there are three further classes of POAH neurons: warm-sensitive, 
cold-sensitive, and temperature-insensitive neurons. Approximately 70% of POAH neurons are 
temperature-insensitive, showing little change in firing rate (FR) during increases or decreases in 
temperature. Warm-sensitive neurons, which compose ~20% of the POAH population, increase 
their FR with rising temperature by a minimum of 0.8 impulses/sec/°C (Boulant, 2006; Imbery, 
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2008). Less than 5% of the population is the elusive cold-sensitive neuron, which increases FR in 
response to decreases in POAH temperature. Cold-sensitive neurons are not inherently 
thermosensitive, but instead receive inhibition from local warm-sensitive POAH neurons. At 
lower temperatures, the tonically-firing cold-sensitive neurons are disinhibited, and therefore 
exhibit a higher FR (Boulant, 2000). 
In 1965, H.T. Hammel used these phenotypes to create a theoretical thermoregulatory 
circuit (Fig. I.1). Hammel proposed that each neuron subtype played a particular role in 
thermoregulation. Temperature-insensitive neurons, which respond neither to temperature 
changes in the brain itself nor to peripheral temperature changes, provide steady tonic inputs, 
serving as a reference point. Warm-sensitive neurons receive input from peripheral temperature 
receptors and combine this information with their own inherent thermosensitivity. Thus these 
temperature-sensitive neurons can serve as both sensors and integrators of temperature input 
(Boulant, 2006). By Hammel’s model, the competitive inputs of these temperature-insensitive 
and temperature-sensitive neurons are what create the temperature set-point. A change in the FR 
of one cell type can override the other. For instance, if the warm-sensitive neurons were to begin 
increasing their FR in response to a rise in central temperature, their excitatory influence on 
warm-effector neurons would override the tonic inhibition provided by temperature-insensitive 
neurons. Warm-effector neurons would then increase their own FRs and induce heat loss 
pathways (Boulant, 2006). 
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Figure I.1 Hammel’s Model for Thermoregulation.  
 
Warm-sensitive (“W”) neurons receive excitatory input from dorsal horn spinal neurons 
(“SP”) and convey this information accordingly to warm-effector (“w”) and cold-effector 
(“c”) neurons, which go on to induce heat loss or heat production. Temperature-
insensitive neurons (“I”) receive no peripheral input, instead providing a tonic input to 
warm- and cold-effector neurons. Dotted lines indicate the frequency of FR input from 
warm-sensitive and temperature-insensitive neurons, with (+) indicating an excitatory 
input and (-) an inhibitory input. Adapted from Boulant, 2006. 
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Subsequent electrophysiological and anatomical studies have supported Hammel’s model 
(Boulant, 2000; Boulant, 2006). Anatomically, biocytin staining of thermosensitivity-
classified neurons revealed that while temperature-insensitive neurons orient their dendritic 
projections parallel to the third ventricle, warm-sensitive neurons orient their dendritic 
projections perpendicular to it, aligning their dendrites to connect with afferent temperature 
pathways passing through the periventricular area and medial forebrain bundle (Fig II.2; 
Griffin, 2004). This lends credence to the theory that warm-sensitive neurons monitor both 
central and peripheral temperature, and that temperature insensitive neurons do not collect 
peripheral temperature information. Furthermore, warm-sensitive neurons have been shown 
to respond not only to incoming peripheral temperature information but also to osmotic 
changes, cardiovascular changes, and even emotional stressors, expanding their role as 
coordinators of temperature control and peripheral information (Oka, 2001; Hori, 1986). 
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Figure I.2 – Camera lucida drawing of warm-sensitive and temperature-insensitive 
neurons.  
 
Neurons’ thermosensitivity phenotype was identified via intracellular 
electrophysiological recording. Neurons were then filled with biocytin stain which was 
subsequently silver-enhanced. On the left are temperature-insensitive neurons, which 
orient their dendrites parallel to the third ventricle and do not react to central or 
peripheral temperature. On the right are warm-sensitive neurons, which orient their 
dendrites perpendicular to the third ventricle and appear to integrate central and 
peripheral temperature information. Adapted from Griffin, 2004. 
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3. Thermoregulatory Efferents of the POAH 
In the event of a significant change in temperature, the POAH must induce the behavioral 
and physiological responses necessary to return core temperature to the set-point. It provokes 
these responses through several descending pathways. 
During a drop in body temperature, organisms pursue heat retention and production 
mechanisms. Rats can produce heat via non-shivering thermogenesis, in which stores of brown 
adipose tissue (BAT) are metabolized (Nagashima, 2000). Caudal lesions between the POAH 
and the dorsomedial hypothalamus (DMH) were shown to induce BAT thermogenesis, and a 
2007 study by Nakamura et. al. showed that injection of the inhibitory neurotransmitter GABA 
into the POAH was sufficient to create BAT thermogenesis as well, suggesting the POAH 
provides tonic inhibition to the non-shivering thermogenesis pathway. 
When body temperature rises, organisms pursue heat loss mechanisms. While humans 
sweat to reduce heat via evaporation, rats can accomplish the same task by licking their fur. The 
salivary secretion required for this behavior can be induced by warming the POAH itself. When 
warmed, the POAH’s parasympathetic projections to the paraventricular nucleus and lateral 
hypothalamus become activated. These hypothalamic nuclei go on to innervate the medulla 
oblongata, which stimulates salivation secretion from the submandibular and sublingual glands 
(Nagashima, 2000).  
Through these and many other mechanisms, the POAH can initiate changes in body 
temperature. Other thermoregulatory efferents of the POAH range from shivering induction via 
midbrain reticulospinal neurons to skin vasodilation via premotor neurons of the medulla 
oblongata (Nagashima, 2000). 
 
11 
 
4. The Paraventricular Nucleus 
As alluded to in the case of the salivating rats, the paraventricular nucleus of the 
hypothalamus (PVN) is known to play a role in thermoregulation. So named due to its proximity 
to the third ventricle, the PVN serves as the brain’s neuroendocrine control center (Figure I.3). It 
gates the release of dozens of circulatory hormones ranging from vasopressin to follicle-
stimulating hormone via its connections with both the anterior and posterior portions of the 
pituitary gland (Sawchenko, 1983). 
The PVN is divided by cell type into two distinct regions: the magnocellular and 
parvocellular subnuclei. Magnocellular neurons, which earn their name from their large cell 
bodies, project to the posterior pituitary gland, where they release the hormones oxytocin and 
vasopressin directly into the bloodstream (Prabha, 2010). Classically represented as the water 
conservation hormone, vasopressin constricts peripheral blood vessels and stimulates water 
reabsorption at the kidney. Oxytocin has been most closely tied with childbirth, initiating milk 
let-down and uterine contractions (Kuzmiski, 2010). 
The smaller parvocellular neurons of the PVN project in part to the median eminence, 
where they release peptides into the hypothalamo-pituitary portal system. These peptides travel 
to the anterior pituitary, where they stimulate the release of a bevy of hormones – ranging from 
follicle-stimulating hormone to thyroid-stimulating hormone – from pituitary neuroendocrine 
cells. Sawchenko and Swanson estimated that the parvocellular regions of the PVN express and 
respond to over thirty neurotransmitters and neurohormones (Sawchenko, 1983). Parvocellular 
cells of the PVN also project to several downstream effectors including the locus coeruleus, 
parabrachial nuclei, and the thoraco-lumbar region of the spinal cord. These connections allow 
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parvocellular PVN neurons to modulate sympathetic respiratory, behavioral, visceral and cardiac 
responses (Prabha, 2010). 
Neurotransmitters in the PVN include norepinephrine, serotonin, and the ubiquitous 
glutamate (Sawchenko, 1983). As in the majority of the brain, glutamate – an excitatory 
neurotransmitter - and its inhibitory counterpart GABA are both present in the PVN. In 
magnocellular cells, metabotropic glutamate receptors have proven important in the long-term 
changes required for oxytocin release (Kuzmiski, 2010). Under basal conditions PVN neurons 
remain largely inactive, unlike their tonically-firing POAH neighbors. This has been tied to a 
high amount of GABAergic input to the PVN. Blocking GABAA receptors with the antagonist 
bicuculline leads to increased excitation of the PVN; however, blocking ionotropic excitatory 
amino acid receptors with the nonselective antagonist kynurenic acid silenced that response. This 
suggests that the majority of PVN cells have a sub-threshold resting membrane potential. Under 
basal conditions, they remain inhibited by GABAergic input; however, even if GABAA receptors 
are blocked, an excitatory neurotransmitter such as glutamate is required to garner a response 
(Prabha, 2010). Thus, the PVN appears to be under the control of a carefully-maintained balance 
of excitatory and inhibitory inputs. Known inputs include the anterior perifornical area and 
parastrial nucleus, but many of these inputs remain unknown (Elmquist, 1997). 
As the brain’s major hormone control center, the PVN is responsible for enacting changes 
in both behavior and autonomic systems such as heart rate, blood pressure and breathing. The 
former is most generally controlled by the limbic system and the hypothalamus; the latter, by the 
hypothalamus and lower brain stem nuclei. The PVN is also a central part of the hypothalamic-
pituitary axis, the “stress circuit” of the brain, and as such plays a role in the bodily changes that 
result from perception of environmental stressors. As a player in the sympathetic nervous 
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system, the PVN receives dense noradrenergic and adrenergic inputs from the locus coeruleus, 
ventral medulla and nucleus tractus solitarius (NTS) (Sawchenko, 1983). Known nearby 
afferents include the suprachiasmatic nucleus, which is intimately tied with circadian rhythms; 
the lateral hypothalamus, involved in feeding and drinking behavior; and the anterior 
hypothalamus – including its preoptic area (Sawchenko, 1983). A less well-defined input is 
angiotensin II, a circulatory hormone that increases during periods of dehydration or 
hemorrhage. When angiotensin II is high in the bloodstream, the PVN releases vasopressin; 
however, the means by which angiotensin II signals the PVN is not well known, as it neither 
crosses the blood-brain barrier nor enters the cerebrospinal fluid of the third ventricle (Prabha, 
2010). 
The PVN plays a role in everything the hypothalamus is known for: homeostatic control 
of fluid levels, metabolism, and behavior. With most of these properties affecting temperature, 
does the thermoregulatory POAH interact directly with the PVN? 
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5. Fever: The POAH and PVN 
Fever provides a useful perspective for an examination of the relationship between the 
POAH and PVN, as both nuclei are involved in the febrile response. Fever itself is a 
hyperthermic state that most commonly results from pathogenic infection. Although the debate 
over whether fever is an adaptive or maladaptive trait continues, prior research has indicated that 
fever can both improve white blood cell function and inhibit growth of certain microbes. As 
such, fever is an indelible component of the immune system’s response to an acute infection 
(Elmquist, 1997).  
Traditionally, cytokines were thought to be the main instigator of fever (Blatteis, 2007). 
Pathogen markers such as the bacterial cell wall component lipopolysaccharide (LPS) cause the 
release of cytokines like interleukin-1 into the bloodstream by white blood cells and other major 
immune system players (Imbery, 2008). These cytokines were classically thought to enter the 
brain at the organum vasculosum laminae terminalis (OVLT), which lies in close proximity to 
the POAH. The blood-brain barrier is particularly permeable at the OVLT, allowing larger 
molecules to enter. OVLT neurons respond to these immune system cues by releasing 
prostaglandin-E2 (PGE2) into the POAH (Boulant, 2000). PGE2 has been shown to both inhibit 
warm-sensitive neurons and excite temperature-insensitive neurons, which leads to a suppression 
of heat loss mechanisms and an increase in heat production. The animal begins retaining and 
producing heat at a higher temperature than 37°C, raising body temperature (Boulant, 2006). 
Recent research has shown that the OVLT-POAH pathway is in fact the slower of two 
mechanisms, as it depends upon both the production of cytokines and the transcription and 
translation of the PGE2-producing enzyme cyclooxygenase-2 (COX-2). Tumor necrosis factor 
(TNF)-α is the first cytokine to circulate in the bloodstream after an intravenous LPS injection, 
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yet it does not appear in the bloodstream until 30 minutes post-injection. Temperature increases 
within 10-12 minutes of LPS injection, before a significant amount of cytokines enter the 
bloodstream (Blatteis, 2005).  Recent research has shifted focus to the liver, which also shows a 
response to peripheral LPS. Liver cells react to LPS by creating C5a, a compound that provokes 
Kupffer cells to activate the hepatic vagal nerve bundle by releasing PGE2. In this case, PGE2 is 
catalyzed by the membrane-associated enzyme PI-PLC rather than COX-2, resulting in faster 
PGE2 production and release (Blatteis, 2007). This nerve has been shown to ultimately stimulate 
the release of norepinephrine in the POAH via the NTS, leading to a much faster rise in 
temperature than that provided by the slower COX-2 dependent OVLT pathway (Imbery, 2008). 
As such, it has been proposed that fever is initiated by one system – most likely, the hepatic 
vagal nerve – and then sustained by the eventual rise in circulating cytokines and the OVLT 
response that results. The NTS’s ventral noradrenergic bundle, which may receive input from the 
liver via the hepatic vagal nerve, releases norepinephrine (NE) into the POAH. NE inhibits 
warm-sensitive neurons and provokes the early temperature rise. Later, the increase in cytokines 
that has long been correlated with fever may take part in initiating a secondary fever phase by 
activating the OVLT, the hepatic vagal nerve, cerebrovascular endothelial cells, or some 
combination of the three (Blatteis, 2005). 
Once the POAH has received an infection signal and begins the thermostat shift, theories 
suggest that the PVN enacts many of the autonomic and endocrine changes necessary for a 
temperature rise. Physiologically, the PVN has been shown to become active during fever 
(Saper, 1998). PVN neurons controlling the autonomic preganglionic neurons essential for the 
shifts in blood flow that are necessary for fever are particularly active during an LPS-induced 
fever. These neurons constrict peripheral blood vessels, driving cutaneous blood to deep vascular 
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beds to increase core body temperature (Elmquist, 1996; Scammell, 1996). When temperature 
exceeds the POAH’s set-point, the PVN reduces mesenteric blood flow. This is part of the 
general response to hyperthermia, in which blood is shunted from deeper vascular beds to the 
skin where heat can dissipate, leading to the well-known flush of fever (Chen, 2010). When the 
body is in the first stages of cultivating a fever, the PVN performs the opposite task: constricting 
peripheral blood vessels to pull cutaneous blood to the body’s core, raising core temperature 
(Scammell, 1996). This in combination with lesion studies and the activation of PVN during 
thermoregulatory responses provides strong evidence for a connection between the POAH and 
PVN. 
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Figure I.3. Anatomical orientation of PVN and POAH.   
Nissl-stained coronal whole-brain slice from a rattus norvegicus adult. The densely 
populated triangular region at the top of the third ventricle is the paraventricular nucleus 
(PVN); immediately ventral to the PVN is the medial portion of the preoptic area 
(POAH), which is bordered laterally by the anterior hypothalamus and lateral 
hypothalamus. Adapted from Brain Maps. 
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6. Anatomical Evidence for POAH-PVN Interaction 
As shown in Figure I.3, the POAH and PVN lie in close proximity to one another 
anatomically, providing an ideal target for retrograde labeling studies. In 1997, Saper and 
Elmquist observed LPS-activated projections from the ventromedial preoptic area (VMPO) to 
the PVN (Elmquist, 1997). Sawchenko’s 1983 survey identified “light” projections from the 
POAH to the PVN, with “more substantial” input rising from the medial POAH to the 
parvocellular division of the PVN (Sawchenko, 1983). Moga and Saper, whom used Fluorogold 
retrograde tracing, identified dense labeling in the medial preoptic after LPS activation (Moga, 
1994). As far back as 1981, scientists concluded that there was “general agreement” that major 
hypothalamic inputs to the PVN included the anterior hypothalamus, periventricular preoptic 
area, medial preoptic area, and lateral hypothalamus (Silverman, 1981). 
The nature of this interaction, however, remains unknown. A large percentage of POAH 
neurons are inhibitory, and the high tonic GABAergic inhibition of the PVN might initially 
suggest that the POAH may be one of the many inhibitory afferents of the PVN (Nakamura, 
2008). However, the PVN shows a differential activation during the fever response, with 
parvocellular regions showing activity during the early phase, and magnocellular regions during 
the later phase. Release of vasopressin within the CNS by the PVN plays a potential role in 
stifling fever, rather than propagating it (Saper, 1998; Hallbeck, 2001). The anterior 
periventricular area of the hypothalamus provides GABAergic input to the PVN; the VMPO, 
meanwhile, provides inhibitory inputs to the anterior periventricular area. As such, Elmquist 
suggested that the POA may disinhibit the PVN by inhibiting the inhibitory periventricular area. 
However, as previously discussed, disinhibition alone is not enough to increase the firing rate of 
PVN neurons; excitatory input is required (Elmquist, 1997; Prabha, 2010). This evidence 
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suggests that there may be a combination of direct glutamatergic excitation of the PVN and 
indirect GABAergic inhibition of inhibitory nuclei projecting to the PVN. 
 
 
 
7. Specific Aim and Hypothesis 
 As the PVN has been identified in several thermoregulatory mechanisms, the nature of 
the interaction between the POAH and the PVN is of central importance to a proper 
understanding of the brain’s thermoregulation network. The POAH has been shown to inhibit 
inhibitory nuclei projecting to the PVN. It has also been shown to provide direct input to the 
PVN itself. These parallel projections suggest that the POAH may indirectly disinhibit the PVN 
while also providing direct excitatory input. To identify any excitatory (i.e., glutamatergic) input 
from the POAH to the PVN, retrograde-labeling nanoparticles conjugated with a polyclonal 
vesicular glutamate transporter type-2 (VGLUT-2) antibody will be injected into the PVN. This 
technique will result in labeling of glutamate-releasing neurons of the POAH.  
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Methods 
 
 
1. Treatment and Preparation 
 
Tissue slices were prepared from male Sprague-Dawley rats (Harlan, 100-150 g). The 
animals were housed in standard conditions and provided food and water ad libitum. As per 
procedures approved by the Animal Care and Use Committee of the College of William and 
Mary, rats were anesthetized with isofluorene and sacrificed by decapitation. Brain tissue 
isolated into a tissue block containing the hypothalamus was sectioned into 500 µm slices of 
sagittal or coronal orientation. The slices were then placed in a submersion recording chamber 
and perfused with a continuous supply of artificial cerebrospinal fluid (aCSF), which contained: 
124 mM NaCL, 26 mM NaHCO2, 10 mM glucose, 5 mM KCl, 2.4 mM CaCl2, 1.3 mM MgSO4, 
and 1.24 mM KH2PO4. The aCSF, aerated with a 95% O2 – 5% CO2 mix, dripped at 1-2 ml/min 
via gravity flow into the recording chamber, which had a volume of 2 ml. See Fig III.1 for a 
schematic of the recording chamber. 
Antibody-conjugated gold nanoparticles (AuNPs) served as the retrograde labeler. The 
AuNPs were composed of a dielectric silica core surrounded by a thin gold coating (diameter = 5 
nm; Nanopartz, Inc.). These gold nanoparticles were conjugated with a polyclonal antibody for 
VGLUT-2 (Millipore) and polyethyleneimine (PEI, Nanopartz, Inc.), and had a peak reflectance 
frequency of 524 nm (Fig. III.2 (a)).  
Probe solution consisting of AuNPs in bovine serum albumin suspension was backfilled 
into glass microelectrodes pulled to a tip diameter of ~2-5 µm and injected into the PVN with a 
nitrogen puffer system. There, the VGLUT-2 antibody conjugated to the AuNPs’ surfaces 
facilitated specific uptake of the AuNPs into glutamate-releasing axon terminals. 
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AuNP transport relies on the transient exposure of VGLUT to the synaptic cleft. VGLUT 
is located on the membrane of synaptic vesicles within the axon terminal. Utilizing a chemical 
gradient maintained by ATP-driven H+-pumps, VGLUTs transport glutamate from the 
cytoplasm into the vesicular lumen to prepare the vesicle for quantal release of glutamate into the 
synaptic cleft (Shigeri, 2004). When glutamate is released into the synaptic cleft the synaptic 
vesicle membrane fuses with the presynaptic membrane, temporarily exposing the membrane-
bound VGLUT to the synaptic cleft (Jung, 2006). The AuNPs were conjugated with a polyclonal 
antibody to VGLUT-2, the primary VGLUT isoform expressed in the hypothalamus (Santos, 
2009). As synaptic vesicles release glutamate into the synapse, this antibody can bind to the 
exposed VGLUT-2, allowing the nanoparticles to hitchhike into newly forming synaptic vesicles 
and thereby be transported into the presynaptic terminal (Figure III.2 (b); Jung, 2006). 
Once encapsulated in a synaptic vesicle, the cationic PEI conjugate utilizes the ‘proton 
sponge effect’ to induce an influx of water into the vesicular lumen. This hydrosaturation 
eventually lyses the vesicle and leaves the nanoparticles free to diffuse to the soma (Figure III.2 
(c); Bergen 2008). Theoretically this diffusion is passive; however, the rapid uptake – with 
probes often visualized in somas dozens of µm away as quickly as 2 hours post-injection – might 
suggest that the AuNPs are assisted by some form of axonal transport mechanism, possibly by 
remaining within vesicles being transported to the soma for degradation (Bergen, 2008; 
Mendoza, 2010). 
Following injection, the AuNPs were allowed to diffuse through the tissue for 6 hours 
(h). Treated slices were then removed from the recording chamber and placed in a 10% formalin 
solution at 12°C. 
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Figure III.1 Diagram of recording chamber.  
 
aCSF was oxygenated with 95% O2 and 5% CO2 within the reservoir. It was then heated by 
the thermoelectric assembly (d) en route to the inner bath (a) within which the tissue was 
placed.  
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Figure III.2 AuNP mechanism of action.  
 
(A) 5 nm gold nanoparticles are conjugated with polyclonal VGLUT-2 antibodies (‘y’-
shape) and PEI (jagged line). (B) At the presynaptic terminal of glutamate-releasing 
neurons, VGLUT-2, ordinarily present on synaptic vesicles within the cytoplasm, is 
temporarily exposed as synaptic vesicles fuse with the presynaptic membrane. The 
VGLUT-2 antibodies attach here, allowing the nanoparticles to ‘hitchhike’ along into 
newly-forming synaptic vesicles. (C) Within the synaptic vesicle, PEI draws in water via 
the proton-sponge effect. The vesicle lyses, allowing the AuNPs to diffuse to the soma. 
By this mechanism, AuNPs injected into the PVN can enter any neuron releasing 
glutamate in the injection area. Adapted from Mendoza, 2010. 
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The 500 µm thick tissues were soaked in a 30% paraformaldehyde/sucrose solution prior 
to being sectioned into 50 µm slices with a freezing microtome (Leica SM-2000R). These slices 
were then transferred to a phosphate-buffered saline solution. The slices were immediately 
mounted on slides and left to dry at room temperature for a minimum of 12 h. 
For the giemsa staining process, slides were first placed in a 50:50 chloroform-alcohol 
solution for 3 h at RT. The slides were then rehydrated by submersion for 5 minutes each in 300 
mL of: 95.5% reagent alcohol, 70% reagent alcohol, and distilled water. This was followed by 
submersion in a phosphate buffer monobasic solution for 5 minutes and 4 minutes in Giemsa 
stain warmed to 60°C. Immersion in 95.5% reagent alcohol for 2 minutes removed excess stain; 
slides were then stored in 300 ml of xylene (Sigma; >98.5%) for 12 h. Coverslips were applied 
with Permount and given 12 h to set prior to microscopy. 
 
2. Data Collection 
 
 
Using a standard upright light microscope (Olympus CX41), AuNPs were visualized in 
dark field illumination and confirmed to be within a cell soma by observing the Giemsa-stained 
somas and probes under bright field illumination (Figure III.3). Upon confirmation, the labeled 
neurons were marked in relation to the injection site on a map adapted from a rat brain atlas 
(Paxinos, 1998). The map used was adjusted based on the tissue slice anatomy to account for 
slight variations in slicing; all coronal slices fell within the domains of the -0.92, -1.30, or -1.40 
mm bregma maps (adapted from figures 22, 23, and 24 of Paxinos, 1998). Sagittal maps were at 
1.1 mm bregma (Figure 105, Pellegrino, 1979). Counters were blinded to whether the tissue was 
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a control or experimental injection, and all labeled cells were verified a second time under a 
100x oil immersion lens. 
 
3. Statistics 
Significance of results was determined by a non-parametric Mann-Whitney U Test, based 
on the total labeled POAH neurons observed for each 500 µm tissue slice. PVN-injected coronal 
slices were compared to PVN-injected slices of sagittal orientation and non-PVN-injected slices. 
To assess the probe distribution per 50 µm slice, a secondary statistical analysis was performed 
via a parametric independent samples t-test. 
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Figure III.3 Neuronal soma labeled with AuNPs.  
 
An AuNP-labeled soma visualized under bright field (top panel), dark field (middle 
panel) and a composite image of bright and dark field (bottom panel). Adapted from 
Mendoza, 2010. 
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Results 
 
Eighteen 500 µm tissue slices were processed and counted. The number of 50 µm slices 
preserved from each 500 µm tissue varied; on average, five 50 µm slices were obtained from 
each.  
Injections of VGLUT-2-conjugated AuNPs into the PVN served as the experimental 
group, with both coronal (n=13) and sagittal (n=2) oriented slices produced. As an in vitro 
experiment, different axonal pathways are severed when tissue is sectioned on different 
anatomical planes; as such, the sagittal oriented slices were used to assess any potential 
advantage to one orientation or the other. These results are summarized in Figure IV.1. 
Control groups included non-PVN injections of VGLUT-2-conjugated probes (n=2) and 
non-injected tissue (n=1). Figure IV.2 compares labeled POAH cells observed in PVN vs. non-
PVN injected tissue. Average labeled POAH cells per injection type and slice orientation are 
summarized in Table IV.1. Figures IV.3, 4, and 5 show typical distribution of probes in a coronal 
PVN-injected slice, a sagittal PVN-injected slice, and a coronal non-PVN-injected slice. 
Statistical results are summarized in Tables IV.2 and IV.3.  
 
Table IV.1 Labeled POAH cells by injection site and slice orientation. 
Injection site, slice orientation n Mean Standard Deviation Standard Error 
PVN, Coronal 13 4 1.73205 0.48038 
PVN, Sagittal 2 5 2.82843 2 
Non-PVN, Coronal 2 .5 0.70711 0.5 
No injection, Coronal 1 0 -- -- 
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Fig IV.1. POAH labeled cells by slice orientation.  
 
Coronal and sagittal injections showed a similar rate of POAH labeling, with an average of 4 
labeled POAH cells per coronal 500-µm slice and an average of 5 labeled POAH cells per 
sagittal 500 µm slice.   
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Fig IV.2 POAH labeled cells by injection site.  
 
AuNPs were injected into either the PVN or a non-PVN region (one injection was higher, 
in the median PO; one injection was lower, in the AHA). Less POAH cells were observed 
when the injection site was not the PVN. 
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Fig IV.3 A coronal PVN injection map.  
 
PVN injection resulted in labeling of the POA, AHA, and LH, as well as local PVN 
neurons and an average of 2.85 labeled cells per 500 µm slice in miscellaneous areas. 
This tissue was approximated to be -1.40 mm bregma and 7.60 mm interaural. Adapted 
from Paxinos, 1998. 
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Fig IV.4 A sagittal PVN injection.  
Sagittal injections showed labeling of the AHA, POA, and LH, as well as an average of 
3.5 labeled cells in miscellaneous areas. Adapted from Pellegrino, 1979. 
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Fig IV.5 A coronal non-PVN injection.  
Injection far above the PVN showed nonspecific labeling, both ipsi- and contralateral. 
This slice is approximated to be at -1.30 mm bregma, 7.70 mm interaural. Adapted from 
Paxinos, 1998. 
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Table IV.2 Mann-Whitney U test results. 
Control U P (two-tailed) 
Non-PVN injections 26.0 0.01904762 
Sagittal 16.0 0.685714 
No injection 13.0 0.1428572 
 
Significant p values at α = .05 are bolded. This is based on total observed labeled POAH 
neurons for each 500 µm tissue slice. 
 
 
 
 
 
Table IV.3 Independent samples t-test results. 
Injection location, 
slice orientation 
n Average labeled 
POAH cells 
Standard 
deviation 
p-value in comparison 
with PVN, coronal 
PVN, Coronal 71 0.7324 0.6752 -- 
PVN, Sagittal 9 1.1111 0.9280 0.13583 
Non-PVN, Coronal 6 0.1667 0.4083 0.04232 
No injection, Coronal 7 0 0 0.00462 
 
Significant p values at α = .05 are bolded. This is based on observed labeled POAH 
neurons per 50 µm slice. 
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 The total data from each treated 500 µm-thick tissue showed a significant increase in 
labeled POAH neurons for PVN-injected tissue over non-PVN injected tissue (Table IV.2). 
When each 50 µm slice was statistically compared, a significant difference was again achieved 
between PVN and non-PVN injections (Table IV.3). Neither the Mann-Whitney U tests 
comparing the complete 500 µm tissues nor the independent samples t-test comparing each 50 
µm slice revealed a significant difference in labeled POAH neurons between sagittal and coronal 
tissue, suggesting that significant numbers of axonal pathways were not severed in one 
anatomical orientation versus another. 
 Other regions within which labeled neurons were commonly observed included the 
anterior hypothalamus (average of 2.46 cells per PVN-injected coronal 500 µm tissue), the PVN 
(average of 2.8 neurons per PVN-injected coronal 500 µm tissue) and, more sparsely, the lateral 
hypothalamus (average of .692 cells per PVN-injected coronal 500 µm tissue). Interestingly, 
some labeled neurons were occasionally found contralateral to the injection site in coronal tissue. 
However, ipsilateral labeling remained significantly more common, with a total average of 12.6 
ipsilateral labeled neurons compared to 0.62 contralateral neurons per PVN-injected coronal 500 
µm tissue slice. 
 Overall, our findings suggest that glutamatergic projections do exist from the POAH to 
the PVN. No significant difference was detected between sagittal and coronal slices. 
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Discussion 
The PVN and Thermoregulation 
Our findings suggest that the PVN does receive glutamatergic input from the 
thermoregulatory POAH. As the PVN exerts control over key autonomic preganglionic neurons 
and temperature-modulating hormones such as vasopressin, this connection has long been 
suspected. Although connections have been identified in retrograde tracing attempts, the 
phenotype of PVN-projecting POAH neurons had not been previously investigated. This study 
provides the first direct evidence of a glutamatergic component of thermoregulatory efferents to 
the PVN. 
As the gatekeeper to the autonomic and endocrine aspects of thermoregulation, the PVN 
shows a strong involvement in heat loss, reducing mesenteric blood flow to move blood towards 
vasodilated peripheral vessels such as the rat tail artery and increasing salivation to promote fur-
licking behavior in rats (Hallbeck, 2001; Nagashima, 2000; Chen, 2010). The PVN also plays a 
role in heat retention and fever propagation. Both parvocellular and magnocellular PVN cells 
show activation during fever; lesions of the PVN result in a reduced febrile response to both 
intracerebroventricular PGE2 injection and intraperitoneal LPS injection (Saper, 1998; Horn, 
1994).  
Direct electrical stimulation of the PVN can be antipyrogenic (Hallbeck, 2001). This may 
be due to projections of vasopressinergic cells to the ventral septal area (Matsunaga, 2000). 
When released in the ventral septal area, vasopressin can inhibit the febrile response while also 
increasing the risk of febrile seizure (Richmond, 2003). However, oxytocin and vasopressin have 
both been implicated as essential in the peripheral blood volume changes required for the acute 
phase febrile response, and do in fact show increased plasma levels after intravenous and 
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intraperitoneal administration of LPS. This suggests vasopressin may play disparate roles in the 
febrile response between the periphery and the central nervous system (Matsunaga, 2000; Saper, 
1992). 
 Evidence of PVN control of thermoregulatory responses in conjunction with the 
identification of direct inputs from the POAH to the PVN suggests that effective, direct 
communication with the PVN is crucial for a fast response to deviations from the temperature 
set-point. While the PVN is able to disinhibit the PVN by inhibiting the anterior periventricular 
area, neurons of the PVN require excitatory input that the POAH could provide with its direct 
projection. This study has shown that such a direct communication does in fact exist between 
thermoregulatory POAH neurons and the PVN, and proven that labeling of this pathway with 
VGLUT-2 antibody-conjugated AuNPs is indeed possible. 
  
 
Methodology 
This project represents one of the first attempts to use the AuNPs for phylogenetic 
classification and connectivity assessment of an unknown circuit. The first and only other study 
to use AuNPs for targeted retrograde tracing of neurons, conducted by Mendoza et al. in 2010, 
focused largely on testing the efficacy of these newly-developed AuNPs, and demonstrated 
impressively selective results. Probes lacking VGLUT-2 antibody showed a significant decrease 
in efficacy; “naked” probes lacking both the VGLUT-2 and PEI conjugates showed worse 
efficacy still. Although it is possible that some nanoparticles are capable of passively diffusing 
into the axon terminal, probes lacking in VGLUT-2 were far less successful at reaching the soma 
(Mendoza, 2010). 
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In the first VGLUT-2 AuNP study, as many as 60 labeled cells were observed per 50 µm 
slice. This study saw far lower numbers, with a maximum of 7 labeled cells observed in a 50 µm 
slice. However, the POAH shows dense input to the dorsomedial hypothalamus, while previous 
retrograde tracing studies have suggested that the POAH provides only light input to the PVN 
(Sawchenko, 1983). Similarly, a study identifying VGLUT-2 expressing cells showed only 
sporadic labeling in the medial preoptic area (Ziegler, 2002). Thus, the reduced numbers of 
labeled cells may be the result of a combination of less cells being available to label and the 
highly selective nature of the probes themselves. 
Although the AuNPs’ selectivity may result in reduced labeling, it also makes them 
highly advantageous for electrophysiology studies. This is, in fact, the reason this application 
was developed. AuNPs exhibit a low biotoxicity and a fast, specific uptake, allowing them to be 
visualized in living in vitro tissue. Other metallic tracers such as Fluorogold and cholera toxin B-
gold provide neither the high specificity nor the low biotoxicity required for this application. 
Moreover, they cannot be visualized in the six to twelve hour window within which in vitro 
tissue can survive (Mendoza, 2010). 
 
Anatomical observations – labeling of the lateral hypothalamus, PVN, and contralateral 
hypothalamic nuclei 
 
 Labeled cells were observed in the lateral hypothalamus (LH) and the paraventricular 
nucleus itself in PVN-injected tissue. The LH does show input to the medial parvocellular cells 
of the PVN (Silverman, 1981). LH neurons also express VGLUT-2 mRNA, confirming that a 
proportion of the LH population releases glutamate as a neurotransmitter (Ziegler, 2002). Local 
glutamate-GABA circuitry plays a large role in PVN control, suggesting that some nearby 
glutamate interneurons may exist (Herman, 2002). This, too, has been backed up with evidence 
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of VGLUT-2 mRNA expression in some magnocellular and parvocellular PVN neurons (Ziegler, 
2002). This data suggests that the number of LH and PVN labeled cells observed is not 
extraordinary. 
The third ventricle serves as a large obstacle between the PVN and contralateral 
hypothalamic nuclei, bringing into question the observed labeled cells in contralateral nuclei. 
However, the suprachiasmatic nucleus has shown significant projections to the contralateral 
portion of the PVN, and it is located beneath the ventral side of the third ventricle (Vrang, 1997). 
As such, contralateral labeling is not unprecedented, although it is presumably quite rare. 
 
Future aims and conclusion 
With POAH projections to the PVN classified, this work provides the foundations for 
several promising projects. In the more immediate future, it would be of use to pursue an in-
depth study of potential GABAergic input to the PVN region and compare it to the results 
obtained here. An AuNP conjugated with vesicular GABA transporter (VGAT) has been 
synthesized and its efficacy tested, and could easily be utilized for this project. Moga observed 
dense labeling in the medial preoptic in a flourogold retrograde tracing study; this, in 
combination with our modest results, suggests that there may be non-glutamatergic input from 
the preoptic to the PVN (Moga, 1994). 
 A particularly exciting endeavor will be to electrophysiologically examine PVN-
projecting glutamatergic POAH cells and characterize them as warm-sensitive, temperature-
insensitive, or silent neurons. A microscope capable of visualizing the probes in living in vitro 
slices will allow for targeted intracellular recordings of AuNP-labeled POAH cells. Preliminary 
targeted recordings have already proven successful, as seen in figure V.1. Intracellular recording 
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allow the AuNPs to truly shine: their low biotoxicity and fast uptake make them ideal for live 
recording of cells with known projections and a known phenotype. More importantly, they can 
be visualized without the dangers of a fluorescent probe, which heats up when fluoresced and 
could alter the neuron’s physiology or even damage the neuron. As AuNPs reflect rather than 
fluoresce, they do not run that risk (Mendoza, 2010). Following recording, the morphology of 
these neurons can then be studied in detail, and perhaps compared to the morphological 
observations that classified warm-sensitive neurons as medial-lateral and temperature-insensitive 
neurons as dorsal-ventral (Griffin, 1994). 
 This project sought to characterize efferent projections from the POAH to the PVN. 
Using a unique retrograde-labeling conjugated gold nanoparticle capable of specifically targeting 
glutamatergic neurons, glutamatergic projections from the POAH to the PVN were identified. 
This technique can now be used to record from PVN-projecting POAH neurons and classified for 
their thermosensitivity, providing the next step in characterizing the finely-tuned neural circuitry 
behind thermoregulation. 
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Figure V.1. Labeled neuron filled with lucifer yellow.  
 
While an intracellular recording was taken of this neuron, lucifer yellow diffused from 
the electrode into the cell. Fluorescence microscopy revealed the soma (outlined in white) 
as well as some dendritic projections (top). A dark cluster of AuNPs is visible in a 
composite image of bright field with fluorescence (bottom, arrow). 
41 
 
References 
 
Bergen, J.M., I. Park, P.J. Horner, and S.H. Pun. (2008). "Nonviral approaches for neuronal 
delivery of nucleic acids." Pharmaceutical Research, 25(5): 983-998. 
 
Blatteis, C.M. (2007). "The onset of fever: new insights into its mechanism." Progress in Brain 
Research, 162: 3-14. 
 
Blatteis, C.M., S. Li, Z. Li, C. Feleder, and V. Perlik. (2005). "Cytokines, PGE2 and endotoxic 
fever: a re-assessment." Prostaglandins & other Lipid Mediators, 76: 1-18. 
 
Boulant, J.A. (2006). "Neuronal basis of Hammel's model for set-point thermoregulation." 
Journal of Applied Physiology, 100: 1347-1354. 
 
Boulant, J.A. (2000). "Role of the preoptic-anterior hypothalamus in thermoregulation and 
fever." Clinical Infectious Diseases, 31: 157-161. 
 
“Brain Maps.” http://brainmaps.org/ajax-viewer.php?datid=94&sname=r18 (accessed April 11, 
2011). 
 
Chen, F., Y. Wang, J.L. Cham, and E. Badoer. (2010). "Inhibition of nitric oxide synthase in the 
paraventricular nucleus prevents the hyperthermia-induced reduction of mesenteric blood 
flow in rats." The American Journal of Physiology - Regulatory, Integrative, and 
Comparative Physiology, 299: R596-R602. 
 
Elmquist, J.K., T.E. Scammell, and C.B. Saper. (1997). "Mechanisms of CNS response to 
systemic immune challenge: the febrile response." Trends in Neuroscience, 20: 565-570. 
 
Griffin, J.D. (2004). "Central thermosensitivity and the integrative responses of hypothalamic 
neurons." Journal of Thermal Biology, 29: 327-331. 
 
Hallbeck, M., D. Larhammar, and A. Blomqvist. (2001). "Neuropeptide expression in rat 
paraventricular hypothalamic neurons that project to the spinal cord." The Journal of 
Comparative Neurology, 433: 222-238. 
 
Hammel, H.T. (1968). "Regulation of Internal Body Temperature." Annual Review of 
Physiology, 30: 641-710. 
42 
 
Herman, J.P., J.G. Tasker, D.R. Ziegler, and W.E. Cullinan. (2002). "Local circuit regulation of 
paraventricular nucleus stress integration Glutamate-GABA connections." Pharmacology 
Biochemistry and Behavior, 71: 457-468. 
 
Hori, T., et al. (1986). "Responsiveness of monkey preoptic thermosensitive neurons to non-
thermal emotional stimuli." Brain Research Bulletin, 17(1): 75-82. 
 
Horn, T., M.F. Wilkinson, R. Landgraf, and Q.J. Pittman. (1994). "Reduced febrile responses to 
pyrogens after lesions of the hypothalamic paraventricular nucleus." The American 
Journal of Physiology, 267: 323-328. 
 
Imbery, T.E., M.S. Irdmusa, A.S. Speidell, M.S. Streer, and J.D. Griffin. (2008). "The effects of 
Cirazoline, an alpha-1 adrenoreceptor agonist, on the firing rates of thermally classified 
anterior hypothalamic neurons in rat brain slices." Brain Research, 1193: 93-101. 
 
Jung, S., R. Morimoto, M. Otsuka, and H. Omote. (2006). "Transmembrane topology of 
vesicular glutamate transporter 2." Biological & Pharmaceutical Bulletin, 29(3): 547-
549. 
 
Kuzmiski, J.B., and J.S. Bains. (2010). "Metabotropic glutamate receptors: gatekeepers of 
homeostasis." Journal of Neuroendocrinology, 22: 785-792. 
 
Matsunaga, W., S. Miyata, A. Takamata, H. Bun, T. Nakashima, and T. Kiyohara. (2000). "LPS-
induced Fos expression in oxytocin and vasopression neurons of the rat hypothalamus." 
Brain Research, 858: 9-18. 
 
Mendoza, K.C., V.D. McLane, S. Kim, and J.D. Griffin. (2010). "In vitro application of gold 
nanoprobes in live neurons for phenotypical classification, connectivity assessment, and 
electrophysiological recording." Brain Research, 1325: 19-27. 
 
Moga, M.M., and C.B. Saper. (1994). "Neuropeptide-immunoreactive neurons projecting to the 
paraventricular hypothalamic nucleus in the rat." The Journal of Comparative Neurology, 
346: 137-150. 
 
Nagashima, K., N. Sadamu, T. Mutsumi, and K. Kanosue. (2000). "Neuronal circuitries involved 
in thermoregulation." Autonomic Neuroscience: Basic & Clinical, 85: 18-25. 
 
Nakamura, K., and S.F. Morrison. (2008). "A thermosensory pathway that controls body 
temperature." Nature Neuroscience, 11: 62-71. 
 
43 
 
Nakamura, K., and S.F. Morrison. (2007). "Central efferent pathways mediating skin cooling-
evoked sympathetic thermogenesis in brown adipose tissue." The American Journal of 
Physiology - Regulatory, Integrative and Comparative Physiology, 292: 127-136. 
 
Oka, T., K. Oka, and T. Hori. (2001). "Mechanisms and mediators of psychological stress-
induced rise in core temperature." Psychosomatic Medicine, 63: 476-486. 
 
Paxinos, G., and C. Watson. (1998). The Rat Brain in Stereotaxic Coordinates. 4th Edition. San 
Diego: Academic Press. 
 
Pellegrino, L., A. Pellegrino, and A. Cushman. (1979). A Stereotaxic Atlas of the Rat Brain. 2nd 
Edition. Plenum Press: New York. 
 
Prabha, K., and T.E. Dick. (2010). "Modulation of cardiorespiratory function mediated by the 
paraventricular nucleus." Respiratory Physiology & Neurobiology, 174: 55-64. 
 
Richmond, C.A. (2003). "The role of arginine vasopressin in thermoregulation during fever." 
Journal of Neuroscience Nursing, 35(5): 281-286. 
 
Santos, M.S., H. Li, and S.M. Voglmaier. (2009). "Synaptic vesicle protein trafficking at the 
glutamate synapse." Neuroscience, 158: 189-203. 
 
Saper, C.B. (1998). "Neurobiological basis of fever." Annals New York Academy of Sciences, 
856: 90-94. 
 
Scammell, T.E., J.K. Elmquist, J.D. Griffin, and C.B. Saper. (1996). "Ventromedial preoptic 
prostaglandin E2 activates fever-producing autonomic pathways." The Journal of 
Neuroscience, 16(9): 6246-6254. 
 
Shigeri, Y., R.P. Seal, and K. Shimamoto. (2004). "Molecular pharmacology of glutamate 
transporters, EAATs and VGLUTs." Brain Research Reviews, 45: 250-265. 
 
Silverman, A.J., D.L. Hoffman, and E.A. Zimmerman. (1981). "The descending afferent 
connections of the paraventricular nucleus of the hypothalamus (PVN)." Brain Research 
Bulletin, 6(1): 47-61. 
 
Swanson, L.W., and P.E. Sawchenko. (1983). "Hypothalamic integration: organization of the 
paraventricular and supraoptic nuclei." Annual Review of Neuroscience, 6: 269-324. 
 
 
44 
 
Vrang, N., J.D. Mikkelsen, and P.J. Larsen. (1997). "Direct link from the suprachiasmatic 
nucleus to hypothalamic neurons projecting to the spinal cord: a combined tracing study 
using cholera toxin subunit B and phaseolus vulgaris-leucoagglutinin." Brain Research 
Bulletin 44(6): 671-680. 
 
Ziegler, D.R., W.E. Cullinan, and J.P. Herman. (2002). "Distribution of vesicular glutamate 
transporter mRNA in rat hypothalamus." The Journal of Comparative Neurology, 448: 
217-229. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45 
 
Acknowledgments 
     
  My acknowledgments have to begin with an extension of my deepest thanks to Dr. John Griffin, 
who has been my mentor in every sense of the word these past four years. In the darkest, direst times of 
research crisis, Dr. Griffin has always been there to lend some good advice and a little bit of sanity. I 
would like to thank my committee members, Dr. Josh Burk and Dr. Matthew Wawersik, for generously 
providing their time and guidance throughout this defense process. Thanks also to my heroic counters 
Andrew Moore and Sarah Cannon, who survived many an hour in the dark of the microscope room to 
make this project happen. And of course, thanks to the rest of Griffin lab, both past and present. It’s truly 
been a pleasure to enjoy their company these past few years. 
Beyond the hallowed halls of the ISC, I would like to thank my friends Alyssa Parker, Barret 
Sowers, Sarah Underwood, Jennie Joyce and Sarah Lesley for putting up with all of my incessant science 
talk these last few months. Last but not least, I would like to thank my parents, Diane and Jim McLane, 
for encouraging and supporting me throughout my educational career. 
 Funding for this project included the College’s Howard Hughes Medical Institute Summer 
Research Fellowship program and NIH grants NS053794, NS065461, and NS053794-S1. 
